Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,242
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/krasnyi-oktyabr-inc-recalls-starfish-seafood-trio-because-possible-health-riskPublished October 9, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 21,441–21,460 of 23,278 recalls

FDA Recall TerminatedTerminated: March 16, 2015Historical recordClass II

Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

by SigmaPharm Laboratories LLC

Reason
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 26, 2016Historical recordClass II

PROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. Manufactured by: Cadila Healthcared Ltd., India. Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. NDC: 68382-041-01

by Zydus Pharmaceuticals USA Inc

Reason
Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: March 9, 2015Historical recordClass II

QVAR¿ (beclomethasone dipropionate HFA), 80mcg Inhalation Aerosol, 50 metered inhalations/120 metered inhalations, packaged in an aluminum cylinder, Mktd. by: Teva Respiratory, LLC, Horsham, PA, Mfd. by: 3M Drug Delivery Systems, Northridge, CA.

by Teva Pharmaceuticals USA

Reason
Defective Delivery System; defective valve
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

ExtenZe 600 mg, 30 tablet box, Manufactured for: Biotab Nutraceuticals, Inc., Pasadena, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

Magic For Men, packaged in 1ct blister pack and 12-pill/bottle, 390 mg Manufactured For: BTQ Ski, Inc., Chicago, IL 60638

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

MiracleZEN Platinum, 1 pill blister pack, 2000 mg capsule, Distributed by: Power Life Distributors, COK Inc., Los Angeles, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

SEXY MONKEY, 2000 mg, 1 count blister, Distributed by A Herbal Bio, Inc., Bayside, NY.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

BOOST ULTRA, sexual enhancement dietary supplement, 12-capsule/bottle. Also packaged in 3 pill bottles and 1 pill packs. BoostUtra.com, Springfield, MO.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: February 3, 2015Historical recordClass I

XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Published
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, F…

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Esbelder Fem Mezcla con L-Carnitina Suplemento Alimenticio,30 capsule bottle, Hecho en Mexico: Soluciones HGC S. de R.L. de C.V. Av. Independencia #1060 Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000251

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Esbelder Man Herbal Blend With L-Carnitine Dietary Supplement, 30 capsule bottle, Made in Mexico: Soluciones S. de R.L. de C.V. Av. Independencia #1060 Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000275

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Esbelder Siloutte Suplemento Alimenticio, 30 capsule bottle, Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000268

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Esbelin Siloutte Te, Suplemento Alimenticio, herbal tea in a gold foil/plastic zip-lock pouch. Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7562684652553

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2015Historical recordClass I

Esbelin Siloutte Mezcal Herbal con L-Carnitine Suplemento Alimenticio, 30 capsule bottle, Hecho En Mexico Por: Soluciones HGC S. de R.L. de C.V. Av. Independicia #1016 Frac. La Rinconada Aguascalientes, Ags. Mex C.P. 20136, UPC 7502011000060

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 10, 2017Historical recordClass I

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

by Pfizer Us Pharmaceutical Group

Reason
Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 18, 2014Historical recordClass I

PRO ArthMax Dietary Supplement tablets, 750 mg, 120 count bottles, Distributed by Human Science Foundation, Los Angeles, CA

by HUMAN SCIENCE FOUNDATION

Reason
Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 29, 2015Historical recordClass I

Acetylcysteine Solution, USP, 10%, 30 mL vial, Rx only, Ben Venue Laboratories, Inc., Bedford, OH, NDC 0054-3025-02

by Ben Venue Laboratories Inc

Reason
Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 20, 2014Historical recordClass II

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 8 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5379-56, UPC 3 0093-5379-56 2.

by Teva Pharmaceuticals USA

Reason
Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
Published
May 28, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 20, 2014Historical recordClass II

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 2 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5378-56, UPC 3 0093-5378-56 5.

by Teva Pharmaceuticals USA

Reason
Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
Published
May 28, 2014
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.